Inovio Pharmaceuticals is trading 9.87% higher at $1.11 after hours, following a regular-session close of $1.01; no clear company-specific announcement explaining the move surfaced in available search results.
- Its investor-relations news page lists September 1, 2026, as its latest announcement.
- A hantavirus-related headline in search results traces to an older article, not fresh company news.